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integration in Saccharomyces cerevisiae
Carlotta Ronda†, Jérôme Maury†, Tadas Jakočiu̅nas†, Simo Abdessamad Baallal Jacobsen, 
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Abstract 
Background: One of the bottlenecks in production of biochemicals and pharmaceuticals in Saccharomyces cerevisiae 
is stable and homogeneous expression of pathway genes. Integration of genes into the genome of the production 
organism is often a preferred option when compared to expression from episomal vectors. Existing approaches for 
achieving stable simultaneous genome integrations of multiple DNA fragments often result in relatively low integra-
tion efficiencies and furthermore rely on the use of selection markers.
Results: Here, we have developed a novel method, CrEdit (CRISPR/Cas9 mediated genome Editing), which utilizes 
targeted double strand breaks caused by CRISPR/Cas9 to significantly increase the efficiency of homologous inte-
gration in order to edit and manipulate genomic DNA. Using CrEdit, the efficiency and locus specificity of targeted 
genome integrations reach close to 100% for single gene integration using short homology arms down to 60 base 
pairs both with and without selection. This enables direct and cost efficient inclusion of homology arms in PCR 
primers. As a proof of concept, a non-native β-carotene pathway was reconstructed in S. cerevisiae by simultaneous 
integration of three pathway genes into individual intergenic genomic sites. Using longer homology arms, we dem-
onstrate highly efficient and locus-specific genome integration even without selection with up to 84% correct clones 
for simultaneous integration of three gene expression cassettes.
Conclusions: The CrEdit approach enables fast and cost effective genome integration for engineering of S. cer-
evisiae. Since the choice of the targeting sites is flexible, CrEdit is a powerful tool for diverse genome engineering 
applications.
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Background
The production of bio-based chemicals, fuels, pharma-
ceuticals and food additives by microbial fermentation 
is a rapidly growing field. There is an increasing demand 
for efficient cell factories that enable the production of 
biofuels and biochemicals from renewable resources at 
low and competitive cost. The knowledge of genetics, 
physiology, biochemistry and large-scale fermentation of 
baker’s yeast Saccharomyces cerevisiae, combined with 
the advent of genome engineering and recombinant DNA 
technology makes it a preferred host for many industrial 
bio-based applications, ranging from biofuels and bulk 
chemicals to nutraceuticals and pharmaceuticals [1–8]. 
Furthermore, S. cerevisiae has the advantage of being 
easy to manipulate genetically with a range of established 
cloning and vector systems [6, 9].
Production organisms with multi-enzyme pathways 
often require precise control of the expression level of the 
associated genes [2, 5, 10]. Besides regulating promoter 
strength, the copy number of genes is a critical control 
point. Both plasmid and genomic integration systems are 
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widely used for heterologous expression of genes in S. cere-
visiae. Plasmid-based systems typically offer limited control 
of copy number, and significant segregational instability of 
plasmids is often observed even during growth in selective 
medium [10]. It has for example been demonstrated that 
plasmid-based gene expression is highly heterogeneous, 
and that both 2µ and CEN/ARS vectors can be difficult to 
maintain at a stable level within the same cell population 
[11, 12]. Genomic integration is therefore the preferred 
alternative to ensure long-term stability and homogeneous 
expression of genes within a population.
Methods that enable fast, sequential or combinato-
rial integrations are valuable for metabolic engineering. 
Several powerful approaches, either plasmid- or PCR-
based, have been demonstrated for genome integra-
tions using selection markers. Such methods typically 
use active recombination systems, such as Cre/LoxP 
and FLP/FRT, to excise the marker without the need of 
counter selection [13, 14]. Recently, Jensen et  al. devel-
oped an efficient set of vectors, the EasyClone vector 
set, that enables fast and simultaneous multiple integra-
tions of genes into specific “safe sites of insertion” with 
the possibility of recycling the selective markers [12]. The 
insertion sites are located between essential elements, 
which limits the occurrence of chromosomal aberrations 
due to the lethal effect this would cause [15]. Based on 
homologous recombination using 500 bp long homology 
arms, this method results in successful integration into 
a single site [12]. However, the efficiency of integration 
decreases when native genes or promoters are present on 
the fragment to be integrated, or in the case of multiple 
simultaneous integrations (unpublished results). Jensen 
et  al. reported 44% integration efficiency for simultane-
ous integration of three heterologous genes at three dif-
ferent loci using selection [12]. Increasing the efficiency 
of targeted integration without selection is therefore 
important for accelerating and potentially automating the 
strain engineering process.
The recent advent of CRISPR/Cas9 for genome engi-
neering has enabled efficient genome editing in different 
organisms such as bacteria [16], mice [17], plants [18], 
fruit flies [19], fish [20] and mammalian cells [21–23]. 
CRISPR/Cas9 has also been applied for targeted single 
and multiple gene deletions in S. cerevisiae by homology-
directed repair of double-strand breaks (DSBs) using 
short oligonucleotides as repair donors, in different strain 
backgrounds [24–29]. The prevalent DSB repair mecha-
nism in S. cerevisiae is native homologous recombina-
tion (HR), and the introduction of a DSB has been shown 
to increase integration of heterologous linear DNA 
fragments with ends homologous to the DSB site [30, 
31]. Harnessing HR for DSB repair, Ryan et  al. recently 
reported the successful integration of a three-part DNA 
assembly into a single chromosomal locus [26], and Mans 
et al. performed a complete deletion of the ACS2 locus in 
combination with a six-part DNA assembly that resulted 
in the deletion of the ACS1 locus [26, 28]. This impressive 
approach, however, most likely requires additional intrin-
sic selection pressure, with the simultaneous deletion of 
these two loci being essential for viability. Furthermore 
both Horwitz et  al. and Jakociunas et  al. have recently 
shown multiplex assembly and integration of multiple 
parts in three loci, albeit with relatively low efficiencies 
[27, 29, 32]. Jakociunas et al. have demonstrated the pow-
erful application of the CRISPR/Cas9 system as a tool for 
metabolic engineering utilizing user-friendly and easy-
to-use USER-technology-based gRNA constructs [27]. In 
order to further expand this existing platform for knock 
out constructions, we wished to investigate whether 
CRISPR/Cas9 together with the DNA brick based Easy-
Clone approach could be employed for targeted one-step 
selection-free integration of multiple genes into the S. 
cerevisiae genome.
Here, we have developed a system, CrEdit (CRISPR/
Cas9 mediated genome Editing), which combines the 
high specificity of CRISPR/Cas9 with the convenient 
genome engineering tool EasyClone for achieving highly 
efficient and accurate simultaneous genomic integration 
of multiple pathway gene expression cassettes in differ-
ent loci in the genome of S. cerevisiae. The gRNA-guided 
Cas9 endonuclease was used to target gene integration 
at selected insertion sites, which resulted in up to 100% 
correct selection-free target integration at the desired 
locus for the donor DNA. CrEdit also enabled simulta-
neous and highly efficient integration of three pathway 
genes involved in the production of β-carotene at three 
different integration sites located on three different 
chromosomes.
Results and discussion
Construction of the CrEdit system
In order to increase the efficiency of targeted integration 
into the S. cerevisiae genome, we decided to combine the 
well-characterized genomic integration sites used in the 
EasyClone system with the RNA-guided endonuclease 
activity of Cas9. Initially, we tested two different designs 
for the system. In the first design, Cas9 was expressed 
from a constitutive promoter, PTEF1, on an ARS/CEN 
based vector, while the gRNA that targets Cas9 to the 
chosen EasyClone integration site was expressed from an 
episomal 2μ-based vector (Figure 1) [24]. In the second 
design, Cas9 was under the control of the inducible PCUP1 
promoter and integrated in the genome, and the gRNA 
supplied on a linearized integrative vector. The first 
design was chosen for its versatile and recyclable aspects, 
while the second design was chosen for the possibility of 
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controlling the expression of Cas9 and gRNAs at lower 
levels. Both types of gRNA carrier plasmids have been 
designed to enable a fast exchange of the gRNA expres-
sion cassettes via USER cloning. Thereby, it is possible 
to conveniently target a new locus by quick and easy 
single-step cloning of the gRNA plasmids [27]. Also, the 
USER-overhang system enables multiplexing of up to five 
gRNAs on one single plasmid [27].
In this study, we show the use of both genomic and 
plasmid versions in combination with the donor DNA 
being provided via EasyClone integration plasmids. The 
donor DNA can contain up to two promoter-gene-ter-
minator sequences, a selection marker flanked with loxP 
sites, and homology arms for homologous recombination 
at the defined insertion sites of the EasyClone system 
[12]. Importantly, for targeting integration site X-3, the 
sequence of the donor integration plasmid was modified 
by eliminating the PAM site (protospacer-adjacent motif, 
i.e. three nucleotides necessary for Cas9 recognition), 
since the PAM is located on a donor homology arm. This 
Figure 1 Schematic overview of the CrEdit system. a Replicative vectors expressing gRNAs and cas9. b Targeted DSBs mediated by Cas9 endonu-
clease activity facilitate the integration of linearized donor plasmids by homologous recombination. Donor plasmids harbor the desired integration 
sequences flanked by homology arms. Selected intergenic safe harbor sites can be used for simultaneous integration of multiple genomic  
expression cassettes for pathway engineering.
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design prevents Cas9 from cutting the target sequence 
once successful integration has occurred. In the other 
sites used, the PAM site is located within a section of the 
genome that is deleted by the successful integration event 
of the two interspaced homology arms. Since the PAM 
sequence is removed in case of completed integration, 
this might have an additional positive effect on obtaining 
correct transformants, since Cas9 keeps cutting in cells 
where integration was not successful. Thereby the DSB 
fails to be repaired, which is lethal for the cells [24].
Targeted single genomic integration of tHMG1
As a proof of concept for the applicability of CrEdit for 
metabolic engineering, we used the well-established 
carotenoid biosynthetic pathway as a model. Carotenoids 
are part of the diverse group of natural compounds called 
isoprenoids, and are synthesized from precursors derived 
from the native mevalonic acid (MVA) pathway (Fig-
ure 2). The tHMG1 gene encodes a truncated HMG-CoA 
reductase, which has been shown to increase carbon flux 
through the pathway, leading to increased isoprenoid and 
carotenoid production [33, 34]. Therefore, we initially 
focused on introducing one copy of the tHMG1 overex-
pression cassette into the S. cerevisiae genome.
In order to test the efficiency of the two different CrEdit 
designs, we decided to test single integration of donor 
DNA with differently sized homology arms. As donor we 
used an EasyClone integrative plasmid containing tHMG1 
with homology arms specific for intergenic site X-2 (Fig-
ure 3a) [15]. The integration efficiencies of all experiments 
are shown in Additional file 1: Table S1. We first tested the 
integration efficiency of using integrative gRNA in combi-
nation with a S. cerevisiae strain harboring genomic Cas9 
under the control of the PCUP1 promoter. Cas9 expres-
sion was induced by addition of Cu2+ 2  h before trans-
formation. We then co-transformed this Cas9-expressing 
strain with the specific donor DNA carrying tHMG1 with 
homology arms of 500, 110 or 60 bp length for site X-2, 
and the integrative gRNA targeting site X-2. An empty 
vector backbone without gRNA was used as a control. The 
resulting transformants were plated onto medium select-
ing for Cas9, the gRNA and the donor selection marker. 
We then analyzed the genotype of at least 16 colonies per 
condition to check for correct insertion at site X-2. When 
relying solely on intrinsic homologous recombination, the 
measured efficiency of correct integration at site X-2 was 
70% with homology arms of approximately 500  bp (Fig-
ure  3b, left panel, −gRNA). As expected, the efficiency 
of correct integration was found to decrease significantly 
when using shorter arms with lengths of either 110 or 
60  bp (Figure  3b, left panel, −gRNA). However, when 
the gRNA targeting X-2 was expressed, close to 100% 
successful integration was obtained at site X-2, regardless 
of the length of the homology arms (Figure 3b, left panel, 
+gRNA). Interestingly, when using the plasmid-based 
gRNA/Cas9 system and in the absence of gRNA, 100% 
correct integrants could only be obtained using 500  bp 
homology arms. Furthermore, and only in that condition, 
a low number of transformants was obtained on plates, 
which points towards a negative effect of cas9 expres-
sion on cells when expressed from the constitutive strong 
TEF1 promoter and in the absence of gRNA. Ryan et al. 
Figure 2 Overview of the biosynthetic pathway for β-carotene 
production. The carotenoid biosynthetic pathway can be recon-
structed in S. cerevisiae by overexpression of the native GGPP 
synthase encoded by BTS1, and co-overexpression of the non-native 
bifunctional phytoene synthase/lycopene cyclase encoded by crtYB, 
and phytoene desaturase encoded by crtI of X. dendrorhous. HMG1 
encodes the major HMG-CoA reductase activity in S. cerevisiae. 
ERG9 encodes a farnesyl-diphosphate farnesyl transferase (squalene 
synthase) that acts in the sterol biosynthesis pathway. IPP isopentenyl 
diphosphate, DMAP dimethylallyl diphosphate, GPP geranyl diphos-
phate, FPP farnesyl diphosphate, GGPP geranylgeranyl diphosphate.
Page 5 of 11Ronda et al. Microb Cell Fact  (2015) 14:97 
reported a decreased fitness of yeast strains expressing 
cas9 from the strong TDH3 promoter [26], while Mans 
et  al. reported that the constitutive expression of cas9 
from the genome and the TEF1 promoter does not affect 
the maximal specific growth rate on glucose based syn-
thetic media [28]. In light of these results, a more detailed 
study of the impact of cas9 expression levels on yeast cell 
physiology and especially the HR machinery is of interest. 
Still, 100% correct integrants were obtained in the pres-
ence of gRNA for all sizes of homology arms (Figure 3c, 
left panel), suggesting that the plasmid-based gRNA/Cas9 
system also is very efficient.
In conclusion, we show that the DSB created by the 
guide RNA-targeted Cas9 endonuclease is instrumental 
for correct integration at a significantly higher efficiency 
than what can be achieved solely by endogenous homolo-
gous recombination. The lower efficiency observed in 
absence of CRISPR/Cas9 is possibly due to the fact that 
native genes tend to recombine at the native locus due 
to the large homology region. Also, expression cassettes 
a
b
c
Figure 3 Integration efficiency of tHMG1 at locus X-2 using different lengths of homology arms. a Overview of the donor DNA fragment bearing 
tHMG1 with differently sized homology arms. b Integration efficiency of the CrEdit system with genomic inducible Cas9 and integrative gRNA. S. 
cerevisiae strain ST1011 harboring PCUP1-cas9 was induced with Cu
2+ 2 h prior to transformation start, and then co-transformed with (left, –gRNA) 
linearized empty vector pCfB257 and linearized donor DNA encoding tHMG1 (for details of donor DNA see Additional file 1), or (right, +gRNA) the 
linearized integrative gRNA vector pCfB2831 targeting X-2 and linearized donor DNA encoding tHMG1. Left panel Efficiency of targeted integration 
at site X-2 when selecting for donor DNA after transformation. Middle panel Efficiency of marker gene integration when not selecting for donor DNA 
after transformation. Right panel Frequency of correct integration at site X-2 determined by genotyping of URA+ colonies. c Integration efficiency 
of the CrEdit system with plasmid-based Cas9 and gRNA. S. cerevisiae strain TC-3 harboring PTEF1-cas9 on the centromeric plasmid pCfB1767 was 
co-transformed with (left, −gRNA) empty vector pCfB2999 and linearized donor DNA encoding tHMG1, or (right, +gRNA) the episomal gRNA 
vector pCfB3020 targeting X-2 and linearized donor DNA encoding tHMG1. Left panel Efficiency of targeted integration at site X-2 when selecting 
for donor DNA after transformation. Middle panel Efficiency of marker gene integration when not selecting for donor DNA after transformation. 
Right panel Frequency of correct integration at site X-2 determined by genotyping of URA+ colonies. Only +gRNA colonies were analyzed since no 
URA+ clones were obtained in the absence of gRNA. The experiment was repeated twice and error bars represent 95% confidence intervals. NA not 
analyzed.
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might integrate elsewhere in the genome possibly via 
break-induced replication (BIR), thus creating strains 
where it becomes difficult to localize the gene of interest. 
The targeted DSB created by Cas9 likely boosts HR at the 
desired integration site.
Targeted genomic integration without selective pressure
Because of the high efficiency observed for integration 
of tHMG1, we investigated if integration of this gene 
expression cassette could be performed even without 
applying selection pressure for the donor DNA marker 
Kl.URA3. We repeated the integration experiment 
described above, however this time plating the transfor-
mants on medium only selecting for gRNA and Cas9. 
When the plasmid-based gRNA/Cas9 CrEdit system 
was used, 99, 90, and 98% efficiency of integration of the 
marker gene was observed for 500, 110 and 60 bp homol-
ogy arms, respectively (Figure 3c, middle panel, +gRNA). 
The PCR analysis at locus X-2 for the resulting Kl.URA3-
positive clones showed 100% correct integration into 
site X-2 for all tested sizes of homology arms (Figure 3c, 
right panel, +gRNA). However, when using the genomic 
CrEdit system with induced PCUP1-cas9, only 19, 3 and 
9% integration efficiency were achieved for 500, 110 
and 60 bp homology arms, respectively (Figure 3b, mid-
dle panel, +gRNA). Despite the lower integration effi-
ciency, PCR analysis of the resulting Kl.URA3-positive 
clones showed 100% correct integration into site X-2 for 
all tested sizes of homology arms (Figure 3b, right panel, 
+gRNA). When the empty vector (−gRNA) was included 
in the transformation, the efficiency of marker integra-
tion was close to zero in all cases, independent on the 
length of the homology arms (Figure 3b, c, middle panels, 
−gRNA). In the case of genomic cas9 and long 500  bp 
homology arms, the genotyping of 16 Kl.URA3-positive 
clones showed approximately 75% correct integration at 
site X-2 (Figure 3b, right panel, −gRNA). Differences in 
promoters between the systems, and the time-limited 
induction of cas9 by the CUP1 promoter in our experi-
mental set-up (2 h prior to transformation) may lead to 
lower levels of Cas9 at transformation start compared to 
the plasmid-based system where cas9 is under the con-
trol of the constitutive TEF1 promoter on a centromeric 
plasmid. In conclusion, the highest efficiency of both 
selection- and non-selection based genomic integration 
was achieved when both gRNA and cas9 were expressed 
from plasmids, and we therefore chose this to be the final 
configuration of the CrEdit system (Figure 1).
Targeted simultaneous multi‑loci integration of three 
carotenogenic pathway genes
In order to speed up the strain construction process, 
it is often desirable to simultaneously insert multiple 
genes into the genome. After having achieved highly effi-
cient insertion of tHMG1 into intergenic site X-2 using 
the CrEdit method, we tested simultaneous integration 
of multiple genes into the genome of S. cerevisiae. As a 
proof of concept, we attempted to introduce the non-
native production of carotenoids in S. cerevisiae via 
expression of the two heterologous genes crtYB and crtI 
of X. dendrorhous combined with overexpression of S. 
cerevisiae geranylgeranyl diphosphate (GGPP) synthase 
encoded by BTS1 [35]. The gene crtYB encodes a bi-
functional enzyme with phytoene synthase and lycopene 
cyclase activity, while crtI encodes a phytoene desaturase 
[36].
Using the plasmid-based CrEdit system, cells express-
ing Cas9 were simultaneously transformed with three 
different large EasyClone donor DNAs for integration of 
PTDH3-crtI (6.6 kb), PTEF1-crtYB (5.8 kb), and PPGK1-BTS1 
(5.1  kb) into three intergenic sites X-3, XI-2, and XII-5 
situated on different chromosomes, using 500 bp homol-
ogy arms. The cells were co-transformed with one episo-
mal vector expressing the three gRNAs targeting these 
three sites, or with the empty vector for the −gRNA con-
trol. Transformants were plated on media selecting only 
for Cas9 and gRNA expressing plasmids. We observed 
that 84% of the derived colonies presented orange pig-
ment formation when the gRNAs were present, indicat-
ing complete β-carotene pathway integration. In contrast, 
we only observed white colonies when the gRNAs were 
absent, indicating that no correct triple integration had 
been achieved (Figure  4a). All colonies were then repli-
cated on single drop-out plates in order to screen for the 
integration of the three independent selection marker 
genes. As expected, all orange colonies were positive 
for all the three marker genes (Figure 4b, left panel). We 
subsequently tested the genotype of 32 orange colonies 
at the three expected integration sites, and observed 
100% correct integration, thereby confirming complete 
pathway assembly (Figure  4b, right panel). In addition, 
we measured β-carotene levels by HPLC in three con-
firmed clones, and demonstrated that 12.7 ± 2.5 mg L−1 
β-carotene was produced (Figure  4c). This proves the 
ability of the CrEdit system to simultaneously integrate 
three large DNA fragments with surprisingly high effi-
ciency (84%) at the correct loci even without selection 
pressure. As for comparison, simultaneous integration 
of three genes has previously been demonstrated with 
44% efficiency when relying on native HR alone and 
when applying selective pressure [12]. It was furthermore 
attempted to repeat the multi-loci pathway integration 
using short homology arms (60  bp) to investigate if we 
could simply use PCR products directly as donors for the 
multiplex integration. However, no viable colonies grew 
on the plates even after 1  week of incubation (data not 
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shown), indicating that longer homology arms are ben-
eficial for multiplex genome integrations. We assume this 
may due to the fact that multi-loci pathway integration 
is quite demanding with regards to coordinated repair 
activity, and long homology arms are easier to utilize for 
the native yeast HR machinery, thereby enabling correct 
simultaneous integration at multiple loci.
The results obtained for simultaneous integration of 
three genes (BTS1, crtYB and crtI) show the ability of 
the CrEdit system to insert very large fragments (up to 
Figure 4 Multiple simultaneous integration of three β-carotene pathway genes. a Picture of colonies after simultaneous integration of BTS1, crtYB 
and crtI on plates without selection. S. cerevisiae (TC-3) harboring a centromeric plasmid constitutively expressing cas9 was co-transformed with: left 
empty vector control and linearized donor DNAs encoding BTS1, crtYB and crtI. Right gRNA vector expressing three gRNAs targeting intergenic loci 
XII-5, XI-2 and X-3, and linearized donor DNAs encoding BTS1, crtYB and crtI. Colonies with successful pathway integration accumulate β-carotene, 
resulting in an orange pigmentation. b Percentage of complete pathway integration with and without the expression of targeting gRNAs.  
c Frequency of correct simultaneous integration of the three genes BTS1, crtYB, and crtI at the specific intergenic loci XII-5, XI-2 and X-3, respectively, 
determined by genotyping. d HPLC analysis of β-carotene production of three independent orange colonies and a non-producing strain as control 
(CEN.PK113-7D). The experiment was repeated twice and error bars in all panels represent 95% confidence intervals.
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17.5  kb in this study) without the need for a selection 
marker, which is very attractive for industrial metabolic 
engineering applications. Industrial strains are often pro-
totrophic, and/or diploid or even polyploid, thus making 
the use of auxotrophic markers challenging. Further-
more, even for haploid auxotrophic strains, the limited 
number of available selection markers typically neces-
sitates recycling of the markers. Several systems can 
be used for looping out genetic elements, including the 
Cre-LoxP and FRT/FLP systems [12–14]. Such methods 
are not only time consuming but can also leave scars, 
which can cause genome instability and rearrangements 
in recombinant strains [37]. Importantly, CrEdit enables 
selection-free and scarless integration of desired DNA 
sequences, thereby limiting the risk for strain instabil-
ity while significantly speeding up strain engineering. 
Moreover, CrEdit is a versatile genome engineering tool, 
since the design of novel gRNAs for alternative integra-
tion sites can be easily achieved using for example the 
recently developed in silico gRNA selection tool, CRISPy, 
which minimizes the potential risk of off-target effects of 
Cas9 activity [23, 27].
Recently, high efficiencies using CRISPR/Cas9 system 
for genome integration have been reported, but most 
systems either still rely on selective pressure or, if selec-
tion was not applied, only short DNA sequences were 
inserted [25, 26]. In the recent work by Horwitz et  al., 
an 11 gene pathway was integrated via 6-part integra-
tion, however only very low efficiency was observed [32]. 
Stovicek et  al. also demonstrated successful multi-part 
assembly at three different loci, yet with relatively low 
efficiencies [29]. In contrast, CrEdit is a versatile sys-
tem for achieving high efficiency of single and multiple 
simultaneous integrations without the need for selection 
(when long homology arms are used). The CrEdit system 
was designed in a way that the PAM sequence is elimi-
nated upon successful integration. The continued cutting 
of the wild-type DNA is thereby possibly contributing to 
the very high efficiency of integration [24].
Further engineering of carotenoid production
A significant amount of work is available on engineer-
ing organisms for production of carotenoids [38–41], 
and in recent years a biosustainable and economically 
attractive production of β-carotene has been achieved 
[34, 42]. In an attempt to further boost β-carotene pro-
duction, we integrated the β-carotene pathway in S. cer-
evisiae strains bearing genetic modifications previously 
reported as being beneficial for the flux to the meva-
lonate pathway. We therefore performed the multi-loci 
integration experiment in a CEN.PK strain carrying a 
down-regulated version of the squalene synthase ERG9 
gene (erg9::Δ-220–176). In this strain, a deletion of an 
upstream section of the promoter causes lower ERG9 
transcript and protein levels, thereby reducing the flux 
towards the competing endogenous sterol biosynthetic 
pathway [27, 43]. We also transformed a CEN.PK strain 
that carried both the erg9::Δ-220–176 modification and 
an overexpression of tHMG1. Orange colonies producing 
carotenoids were obtained with high efficiency in both 
genetic backgrounds (Additional file 1: Figure S1). It was 
also observed that these latter strains were clearly less 
orange compared to the unmodified CEN.PK strain only 
expressing the β-carotene pathway (compare Figure  4 
and Additional file  1: Figure S1). β-carotene concentra-
tions were measured and it was shown that the additional 
genetic modifications did not lead to an increase in the 
β-carotene levels. A significant decrease in β-carotene 
concentration was even observed for the strain bearing 
both erg9::Δ-220–176 and the overexpression of tHMG1 
(Additional file 1: Figure S1). Indeed, Verwaal et al. have 
shown that the desaturation of phytoene, catalyzed by 
CrtI, is a rate-limiting step in carotenoid production, and 
that an increase of the total carotenoid accumulation is 
largely caused by a significant increase of this precur-
sor [35]. As phytoene is color-less, it is expected that its 
accumulation in the strains improved for precursor avail-
ability results in the less intense coloration of the yeast 
colonies. In order to avoid this precursor accumulation, it 
may be possible to further boost the expression of crtI by 
integrating this pathway gene in more copies [35].
Conclusion
In summary, we were able to demonstrate the ability of 
the CrEdit system to simultaneously integrate up to three 
large DNA fragments with high efficiency even without 
selective pressure into different genetic backgrounds, 
supporting the strength and robustness of the method.
CrEdit combines the stability and versatility of the 
EasyClone vector system with the precision and effi-
ciency of CRISPR/Cas9, thereby significantly increasing 
the efficiency of genome integrations in S. cerevisiae. We 
demonstrate how this system can be used for simultane-
ous integration of multiple genes with high efficiency, 
even without selection for donor DNA. CrEdit is also 
very efficient in integrating large fragments at single loci 
using short homology arms of 60 bp that can be included 
in PCR primers. This facilitates quick and easy exchange 
from one integration site to another. A further advan-
tage of the primer-based preparation of donor DNA 
is that the PAM recognition site can easily be removed 
from the short homology arms. Provided that a suitable 
PAM sequence is present at the genomic site of inter-
est, the system can easily be developed for other genome 
engineering applications, such as combining integrations 
with gene deletions, defined site-specific mutagenesis, 
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gene replacements, promoter exchange, protein domain 
swapping, in a scarless and selection-free manner. We 
therefore believe that CrEdit will be a valuable genome 
engineering tool to facilitate fast and cost-effective pro-
duction strain engineering.
Methods
Strains and media
Saccharomyces cerevisiae CEN.PK strains were obtained 
from Peter Kötter (Johann Wolfgang Goethe-University 
Frankfurt, Germany). All yeast strains used in this study 
were derivatives of CEN.PK (Additional file 1: Table S2). 
All standard cloning was carried out using E. coli strain 
DH5alpha. Media and standard genetic techniques used 
for manipulating yeast strains were performed as previ-
ously described [44]. Synthetic complete medium as well 
as drop-out media and agar plates were prepared using 
premixed drop-out powders (Sigma-Aldrich). All chemi-
cals were obtained from Sigma-Aldrich. Escherichia coli 
transformants were grown in standard Luria–Bertani 
(LB) medium containing 100 µg mL−1 ampicillin.
Construction of plasmids for single targeted integration
All plasmids are described in Additional file  1: Table 
S3, and all gRNA sequences are listed in the Additional 
file  1 as well. Construction of expression plasmids used 
as donor DNA for integration is explained in detail 
in the Additional file  1. For design of all gRNA tar-
get sequences, the overall design was based on DiCarlo 
et al. [24] (Additional file 1: Table S4), and for designing 
the target sequence the program CRISPy was used [23, 
27]. gRNA plasmid pCfB2831 used for integrating the 
gRNA X-2′ (targeting site X-2) into chromosomal site 
X-3 [15] was constructed by amplifying a gRNA expres-
sion cassette (ordered from Integrated DNA Technolo-
gies as gBlock), gRNA_X-2′ (Additional file 1: Table S5), 
with primers PR-10735/PR-10736 (Additional file  1: 
Table S6), and subsequent USER cloning into AsiSI/Nb.
BsmI-digested pCfB257 according to Jensen et al. [12]. To 
construct the episomal gRNA plasmid pTAJAK-76 (tar-
geting site X-2), a backbone-cloning vector was created 
for USER cloning of the gRNA expression cassettes by 
amplifying and re-ligating pESC-LEU with TJOS-97F and 
TJOS-97R. Secondly, the resulting vector was amplified 
using the primers TJOS-108 and TJOS-102R in order to 
remove the KlLEU2 marker. The NatMXsyn marker was 
then amplified from pCfB2180 (GeneArt) with the prim-
ers TJOS-106F and TJOS-106R, and USER-cloned into 
the vector lacking the KlLEU2 marker, resulting in plas-
mid pTAJAK-71. Finally, to target site X-2 [15] with Cas9, 
a gRNA expression cassette was ordered from Integrated 
DNA Technologies as gBlock, gRNA_X-2 (Additional 
file  1: Table S5), and amplified with following primers: 
TJOS-62, TJOS-65. Amplified gRNA was USER cloned 
into pTAJAK-71, which was previously digested with 
AsiSI/Nb.BsmI, resulting in the plasmid pTAJAK-76.
Construction of plasmids carrying multiple gRNAs
First, a backbone-cloning vector was created for USER 
cloning of the gRNA expression cassettes by ampli-
fying and re-ligating pESC-LEU with TJOS-97F and 
TJOS-97R. Secondly, the resulting vector was amplified 
using the primers TJOS-108 and TJOS-102R in order 
to remove the KlLEU2 marker. The KanMXsyn marker 
was then amplified from pCfB2179 (GeneArt) with the 
primers TJOS-106F and TJOS-106R, and cloned into 
the vector lacking the KlLEU2 marker, resulting in plas-
mid pTAJAK-72. Finally, to target the sites X-3, XI-2 and 
XII-5 [15] with Cas9, gRNA expression cassettes [24] 
were ordered from Integrated DNA Technologies as 
gBlocks (gRNA sequences are listed in Additional file 1: 
Table S4) and amplified with following primers: TJOS-
62/TJOS-66 (gRNA_X-3); TJOS-63/TJOS-67 (gRNA_
XI-2) and TJOS-64/TJOS-65 (gRNA_XII-5). Amplified 
gRNAs were USER cloned into pTAJAK-72, which was 
previously digested with AsiSI/Nb.BsmI, resulting in the 
plasmid pTAJAK-92 according to Ref. [27].
Transformation protocol for single integration
Plasmids were transformed into S. cerevisiae cells using 
the lithium acetate transformation protocol [45]. Ini-
tially, PCUP1-cas9 was integrated into EasyClone site X-4 
by transforming CEN.PK102-5B with the integrative 
vector pCFB1129 resulting in strain ST1011 (Additional 
file 1: Table S3). When transforming strain ST1011, Cas9 
transcription was induced by adding 200 µM CuSO4 2 h 
before harvesting the cells for transformation. Prior to 
transformation, donor DNA was prepared as follows. For 
500  bp homology arms, the integrative vector pCfB772 
was digested by NotI and column-purified (Nucelospin 
Gel and PCR cleanup kit, Macherey Nagel). For shorter 
homology arms, pCfB772 was amplified by PCR using 
primer sets PR-9706/PR-9707 (110  bp) or PR-9704/
PR-9705 (60 bp), DpnI-treated and resolved on 1% aga-
rose gel containing SYBR®-SAFE (Invitrogen) and purified 
using NucleoSpin® Gel and PCR Clean-up kit (Mach-
erey Nagel). For single integration, 1 µg donor DNA and 
1 µg NotI-linearized integrative gRNA plasmid or 500 ng 
undigested episomal gRNA plasmid was co-transformed 
into competent yeast cells. Cells were plated on media 
that selected for the presence of the gRNA (KlLEU2) and 
Cas9 (SpHIS5), and optionally donor marker (KlURA3) 
where stated. When colonies appeared, the transforma-
tion plates were replicated on selective plates (SC-LEU, 
SC-URA, SC-HIS) to screen for colonies with integrated 
selection markers. Correct integration at the specific 
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genomic locus was verified by colony PCR with following 
primers: PR-2221/PR-901 (X-2: PTEF1-tHMG1).
Transformation protocol for multiple integration 
of carotenoid pathway
To simultaneously integrate three genes required for 
carotene production, 3 μg of each carrier plasmid (pTA-
JAK-94, pTAJAK-95, pTAJAK-12) were linearized by NotI 
digestion. S. cerevisiae strain TC-3 [27] was co-trans-
formed with these linearized donor plasmids plus 1 μg 
of triple gRNA plasmid pTAJAK-92. Cells were plated 
on media that selected for the presence of the gRNA 
(kanMX) and Cas9 (TRP1) plasmids. When colonies 
appeared, the transformation plates were replicated on 
selective plates (SC-LEU, SC-URA, SC-HIS) to screen 
for colonies with integrated selection markers. To screen 
for correct integrations to the expected loci of carotene 
genes, colony PCR was performed with following prim-
ers: PR-2221/PR-903 (X-3: PTDH3-crtI); PR-2221/PR-909 
(XI-2: PTEF1-crtYB); PR-2221/PR-899 (XII-5: PPGK1-
BTS1). The experiment was carried out in triplicate, and 
statistical analysis (one-tailed Student’s t test) was per-
formed on the complete data set. Multiple integration 
of carotenoid pathway was further performed in strains 
TC-23 and ST3450, according to the protocol mentioned 
above. Strain TC-23 harbors a erg9::Δ-220–176 genetic 
modification [30]. Strain ST3450 was obtained by trans-
forming S. cerevisiae strain TC-23 with a NotI linearized 
pCfB2996 and transformants were selected on medium 
containing nourseothricin. Strain ST3450 therefore har-
bors erg9::Δ-220–176 and a copy of PTEF1-tHMG1 inte-
grated at chromosome locus X-2.
β‑Carotene quantification
Three independent orange colonies from S. cerevisiae 
TC-3 containing the three expression cassettes for BTS1, 
crtYB and crtI were used to inoculate test tubes contain-
ing 4 mL of drop out medium per well. As a reference, a 
colony of S. cerevisiae CEN. PK 113-7D was inoculated 
in the same conditions, and all cells were cultivated at 
30°C with 300 r.p.m shaking. After approximately 48  h 
of cultivation, 3.5  mL of cultivation broth was centri-
fuged for 5  min at 4,000  rpm. Then supernatants were 
discarded and cell pellets resuspended in 0.2 mL of mil-
liQ water. Cell suspensions were transferred to screw-cap 
tubes, suitable for subsequent cell breakage in a Precellys 
homogenizer. Glass beads and 1 mL of hexane were added 
to the cell suspension and cells were mechanically lysed 
for four cycles, each of 20  s at 6,500  rpm. Tubes were 
placed on ice for 1 min in between each lysis cycle. Sub-
sequently, tubes were centrifuged for 5 min at 10,000 rpm 
to separate cell debris, aqueous and solvent fractions. The 
hexane fraction was collected in glass vials. Hexane was 
then evaporated in a rotary evaporator, under vacuum, 
and dry extracts were re-dissolved in 1  mL of ethanol 
99%. Extracts were then analysed by LC–MS. LC–MS 
data was collected on Orbitrap Fusion equipped with a 
Dionex brand Ultimate 3000 UHPLC pumping system 
(ThermoFisher Scientific, Waltham, MA, USA). Samples 
were held in the autosampler at a temperature of 10.0°C 
during the analysis. 2 μL injections of the sample were 
made onto a Supelco Discovery HS F5-3 HPLC column, 
with a 3 μm particle size, 2.1 mm i.d. and 150 mm long. 
The column was held at a temperature of 30.0°C. The sol-
vent system used was Solvent A “Water with 0.1% formic 
acid” and Solvent B “Acetonitrile with 0.1% formic acid”. 
The flow rate was 1.000 mL min−1 with an initial solvent 
composition of %A = 75, %B = 25.0 held until 3.0 min, 
the solvent composition was then changed following a 
linear gradient until it reached %A = 0.0 and %B = 100.0 
at 15.0 min. This was continued until 20 min, when the 
solvent was returned to the initial conditions and the col-
umn was re-equilibrated until 25  min. The column elu-
ent flowed directly into the Heated ESI probe of the MS 
which was held at 325°C and a voltage of 3,500 V. Profile 
data was collected in positive ion mode with resolution 
setting of 30K and scan range (m/z) = 50–600. The other 
MS settings were as follows, sheath gas flow rate of 60 
units, Aux gas flow rate of 20 units, sweep gas flow rate 
of 5 units, ion transfer tube temp was 380°C, maximum 
injection time of 100 ms, S-lens RF level = 60 V, using 1 
Microscans and AGC target = 200,000 counts.
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